Ovarian cancer is the second most common gynecologic malignancy in the Unit
ed States and causes more deaths than any other cancer of the female reprod
uctive system. Approximately two-thirds of patients have tumors that have s
pread beyond the pelvis at the time of diagnosis. Ovarian tumors arise from
the surface epithelium or mesothelium, germ cells, or the gonadal stroma.
Epithelial ovarian tumors include serous, mucinous, endometrioid, clear cel
l, and undifferentiated tumors. In general, the likelihood of malignancy in
creases with increasing solid-tissue elements and thicker septa. Surgery is
central to the management of ovarian cancer. At the initial exploratory la
parotomy, surgicopathologic staging and debulking of the tumor are undertak
en. Patients with advanced cancer frequently undergo second-look surgery af
ter chemotherapy to detect any residual disease. CT can provide staging inf
ormation for preoperative planning and determination of surgical resectabil
ity, demonstrate tumor response to therapy, and allow detection of persiste
nt or recurrent disease. However, a major limitation of CT is the lack of s
ensitivity for detection of small tumor implants, especially on the small i
ntestine or mesentery. Dedicated CT of the pelvis is best performed with sp
iral CT. Ovarian carcinoma can spread by means of intraperitoneal implantat
ion, lymphatic invasion, and hematogenous dissemination.